Mounjaro 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F03S5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,472
Award facts
- Contract value 100% obligated
- $31,471.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,471.86 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens (0.5 mL) on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist indicated for the treatment of type 2 diabetes, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need to support pharmaceutical requirements across military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. The parent IDC serves as a comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen's consistent performance under this vehicle demonstrates the company's capability to efficiently fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains for military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F03S5?
SPE2DR26F03S5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F03S5 worth?
The government has obligated $31,472 on SPE2DR26F03S5.
Is contract SPE2DR26F03S5 an order under another contract?
Yes. SPE2DR26F03S5 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03S5 competed?
The extent of competition for SPE2DR26F03S5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award